Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (211-220 of 374) with videos related to

Pageof 38
Sort By:
Bone Marrow Transplantation|September 28, 2024
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimensJesús Duque-Afonso, Paraschiva Rassner, Kristin Walther, et al.
Cell|December 25, 2025
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunityJian Gu, Yu Li, Qiuyang Chen, et al.
Frontiers in Immunology|February 4, 2026
Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammationThomas Meyer, Robert Meyer, Maren Hackenberg, et al.
Bioactive Materials|September 9, 2024
A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapyIsis Wolf, Jonas Storz, Susanne Schultze-Seemann, et al.
Leukemia|February 20, 2026
The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1Khalid Shoumariyeh, Stefan Haug, Juliana Schwaab, et al.
Oncogene|January 20, 2019
B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer modelMartin Köhler, Sophia Ehrenfeld, Sebastian Halbach, et al.
Nature Nanotechnology|August 9, 2011
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironmentGeorgy Mikhaylov, Ursa Mikac, Anna A Magaeva, et al.
Cancer Gene Therapy|July 6, 2022
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemiaPatricia K Grüninger, Franziska Uhl, Heike Herzog, et al.
Leukemia|January 25, 2020
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activityRomana R Gerner, Sophie Macheiner, Simon Reider, et al.
Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.
Pageof 38

Showing results (211-220 of 374) with videos related to

Sort By:
Pageof 38
Bone Marrow Transplantation|September 28, 2024
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimensJesús Duque-Afonso, Paraschiva Rassner, Kristin Walther, et al.
Cell|December 25, 2025
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunityJian Gu, Yu Li, Qiuyang Chen, et al.
Frontiers in Immunology|February 4, 2026
Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammationThomas Meyer, Robert Meyer, Maren Hackenberg, et al.
Bioactive Materials|September 9, 2024
A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapyIsis Wolf, Jonas Storz, Susanne Schultze-Seemann, et al.
Leukemia|February 20, 2026
The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1Khalid Shoumariyeh, Stefan Haug, Juliana Schwaab, et al.
Oncogene|January 20, 2019
B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer modelMartin Köhler, Sophia Ehrenfeld, Sebastian Halbach, et al.
Nature Nanotechnology|August 9, 2011
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironmentGeorgy Mikhaylov, Ursa Mikac, Anna A Magaeva, et al.
Cancer Gene Therapy|July 6, 2022
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemiaPatricia K Grüninger, Franziska Uhl, Heike Herzog, et al.
Leukemia|January 25, 2020
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activityRomana R Gerner, Sophie Macheiner, Simon Reider, et al.
Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.
Pageof 38